KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Neogenomics (NEO) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Neogenomics (NEO) over the last 15 years, with Q2 2023 value amounting to $127.1 million.

  • Neogenomics' Shares Outstanding rose 116.55% to $127.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $127.1 million, marking a year-over-year increase of 116.55%. This contributed to the annual value of $126.9 million for FY2022, which is 226.13% up from last year.
  • According to the latest figures from Q2 2023, Neogenomics' Shares Outstanding is $127.1 million, which was up 116.55% from $127.2 million recorded in Q1 2023.
  • Neogenomics' 5-year Shares Outstanding high stood at $127.2 million for Q1 2023, and its period low was $95.3 million during Q1 2019.
  • For the 5-year period, Neogenomics' Shares Outstanding averaged around $116.2 million, with its median value being $119.9 million (2021).
  • Per our database at Business Quant, Neogenomics' Shares Outstanding soared by 2740.69% in 2019 and then soared by 116.55% in 2023.
  • Over the past 5 years, Neogenomics' Shares Outstanding (Quarter) stood at $104.8 million in 2019, then grew by 6.96% to $112.1 million in 2020, then grew by 10.74% to $124.1 million in 2021, then increased by 2.26% to $126.9 million in 2022, then rose by 0.18% to $127.1 million in 2023.
  • Its Shares Outstanding stands at $127.1 million for Q2 2023, versus $127.2 million for Q1 2023 and $126.9 million for Q4 2022.